Skip to main content
Clinical Trials/NCT05272137
NCT05272137CompletedNot Applicable

Prospective Data Collection to Evaluate the Feedback Control of the Saluda Medical's Evoke Spinal Cord Stimulation System in the Treatment of Patients With Chronic Pain of the Trunk and/or Limbs

Saluda Medical Pty Ltd1 site in 1 country2 target enrollmentStarted: February 4, 2022Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
2
Locations
1
Primary Endpoint
ECAP Measurement in Microvolts

Study Overview

Brief Summary

The objective of this multicentre study is to collect electrophysiological and device data from the Evoke Closed-Loop SCS system in the treatment of chronic pain of the trunk and/or limbs, in a real world setting under normal conditions of use.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Patient approval for data collection and transfer of de-identified data to sponsor.

Exclusion Criteria

  • No further exclusion criteria.

Outcomes

Primary Outcomes

ECAP Measurement in Microvolts

Time Frame: through 6 months post-implant

Evoked Compound Action Potentials (ECAPs) as a measure of spinal cord activation

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Saluda Medical Pty Ltd
Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials